News
Lumonus inks joint venture with NY cancer centre to scale AI oncology
Lumonus, a GenesisCare spinout chaired by Merrick Howes, is partnering with a New York cancer centre to co-develop automated radiotherapy planning tools.
Chairman, Lumonus
Merrick Howes
Roles
Coverage
Stories naming Merrick Howes. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Series B
$25m
Lumonus AI raises $25 million to embed AI in cancer care
Sydney health-tech firm Lumonus AI has secured a $25 million Series B led by Aviron Investment Management with returning backer Oncology Ventures, to grow its US presence and develop medical-data tools.
6 deals
Brandon Capital news
Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.
Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com